Enhance your clinical and molecular laboratory knowledge with our webinars. Led by prominent physicians, laboratory leaders, subject matter experts, and Abbott scientific professionals, our webinars provide insight on the latest information in molecular diagnostics.
Presented on December 1st, 2021 | Duration: 55m
Outlines Abbott's findings on the new HIV subtype L and the importance of global viral surveillance. Discusses virus diversity and mutations within HIV and SARS-CoV-2 its impact on diagnostic testing, prevalence within the global and US populations (including the various subtypes that exist in HIV and SARS-CoV-2), and the importance of monitoring viral evolution and its impact on detection.
Presented on March 29th, 2021 | Duration: 55m 48s
Alinity m Resp-4-Plex assay provides simultaneous qualitative detection and differentiation of Flu A, Flu B, Respiratory Syncytial Virus (RSV) and SARS-CoV-2 on the fully automated Alinity m system. This webinar will discuss the design, development and clinical performance of the Alinity m Resp-4-Plex assay.
Presented on March 22nd, 2021 | Duration: 49m 51s
Viral diversity presents an ongoing challenge for diagnostic tests, which must be designed to accurately detect all current and future circulating strains. This webinar aims to help better understand viral diversity and the impact it has on diagnostic tools, explore the current state of SARS-CoV-2 surveillance, and discuss how to stay ahead of the next pandemic with Abbott’s Pandemic Defense Coalition.
Presented on July 8th, 2020 | Duration: 1h 14m
Discusses design and development of the SARS CoV-2 diagnostic assay as well as a review of different strategies on the implementation of SARS-CoV-2 molecular testing under FDA Emergency Use Authorization only (EUA) in a US Integrated Hospital Delivery Network (IDN).
Presented on September 8th, 2020 | Duration: 46m
Reviews the available molecular methodologies for identifying gene rearrangements specifically focusing on ALK and ROS1 gene rearrangement testing in non-small cell lung cancer, including overview of the technology, the current recommendations, common practices and challenges associated with these methodologies.
: 36m 47s
: 11m 58s
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.